age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
80.33398
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 15,306
| 9,417.1719
| null | 16
|
white
| 17.097656
| 27
| 0.8479
| 0.750977
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 9
| 56
| 14.199219
| 75
| 20
| 37
| 337
| 3.599609
| null | 1.199951
| 142
| 7.399414
| null | null | null | null | null | null | 2.839356
| 2,027
| 0
|
62.84497
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 79,451
| 59,804.6562
| null | 51
|
white
| 42.09375
| 59
| 0.284973
| 0.175995
| 20
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 40
| 18.097656
| 158
| 28
| 37.59375
| 240
| null | null | 4.5
| 135
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.370606
| 7
| 1
|
56.91199
|
male
| 0
| 14
|
Lung Cancer
|
Cancer
| 1
| 15
|
$25-$50k
| 9
| 13,620
| 12,023.5703
| null | 9.333328
|
white
| 23.898438
| 41
| 0.529907
| 0.20697
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr before sadm
| -1
| 60
| 7.099609
| 140
| 40
| 38.29688
| 304.75
| 3
| 0.599976
| 0.799927
| 136
| 7.439453
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 40
| 1
|
44.47897
|
female
| 0
| 22
|
Lung Cancer
|
Cancer
| 1
| 13
|
$25-$50k
| 100
| 25,121
| 20,401.625
| null | 13
|
white
| 32.898438
| 28
| 0.012999
| 0
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.4
|
dnr after sadm
| 1
| 67
| 8.099609
| 107
| 8
| 36.29688
| 381.625
| 2.399902
| 0.399963
| 1.399902
| 136
| 7.339844
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 3.907715
| 111
| 1
|
29.13599
|
male
| 0
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 18
| null | 0
| 20,860
| 16,367.9531
| null | 9.666664
|
white
| 31.199219
| 42
| 0.588989
| 0.480957
| 1
| 0
| 0
|
yes
| 0.2
| 0.05
|
dnr after sadm
| 1
| 67
| 27.898438
| 112
| 24
| 38.29688
| null | 1.899902
| 3.699707
| 1.099854
| 118
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 59
| 1
|
82.06396
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 3,265
| 2,432.3867
| null | 14
|
white
| 18.796875
| 37
| 0.821899
| 0.709961
| 1
| 1
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 4
| 70
| 16.898438
| 80
| 20
| 36.09375
| 290.4375
| null | null | 1.5
| 135
| 7.489258
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 2,024
| 0
|
54.63699
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 10,749
| 8,246.9922
| null | 12
|
white
| 21.5
| 40
| 0.875
| 0.791992
| 1
| 0
| 0
|
no
| 0.5
| 0.2
|
no dnr
| 12
| 79
| 10.099609
| 124
| 42
| 40.09375
| 227.5
| 4.099609
| 1
| 1.199951
| 132
| 7.489258
| null | null | null | null | null | null | 2.42627
| 2,024
| 0
|
90.89099
|
female
| 0
| 16
|
Colon Cancer
|
Cancer
| 2
| 11
| null | 0
| 13,201
| 10,254.375
| null | 6
|
other
| 15.199219
| 27
| 0.791992
| 0.56189
| 1
| 1
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 1
| 81
| 7
| 80
| 20
| 36.5
| 323.75
| 3.599609
| 0.899902
| 1.599854
| 135
| 7.30957
| null | null | null | 2
| 2
| null | 2
| 64
| 1
|
70.80396
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 4
| 12
| null | 0
| 13,253
| 10,580.3281
| null | 7.5
|
white
| 24.097656
| 33
| 0.521973
| 0.199982
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.1
|
dnr after sadm
| 1
| 73
| 11.798828
| 120
| 28
| 36.09375
| 395.1875
| 3.399902
| 0.5
| 1.199951
| 135
| 7.449219
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 18
| 1
|
82.11896
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
| null | 0
| 3,189
| 2,218.0117
| null | 12
|
white
| 18.296875
| 23
| 0.827881
| 0.718994
| 1
| 1
| 1
|
no
| 1
| 0.75
|
no dnr
| 3
| 92
| 6.299805
| 60
| 24
| 36.29688
| null | null | null | 1.599854
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 3.983887
| 2,022
| 0
|
30.03999
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 0
| 17,692
| 9,315.7969
| null | 16.5
|
black
| 18.398438
| 12
| 0.932983
| 0.907959
| 1
| 0
| 0
|
no
| 0.85
| 0.85
|
no dnr
| 12
| 89
| 9.699219
| 102
| 24
| 38.69531
| null | 2.299805
| 0.399963
| 0.5
| 146
| null | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.202637
| 2,022
| 0
|
83.65796
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 6,931
| 5,280.9766
| null | 5.5
|
white
| 20.296875
| 25
| 0.793945
| 0.667969
| 1
| 0
| 0
|
no
| 0.5
| 0.125
|
dnr after sadm
| 1
| 95
| 18.699219
| 104
| 25
| 37.29688
| 504.0625
| null | null | 1.199951
| 146
| 7.5
| null | null | null | 1
| 3
|
no(M2 and SIP pres)
| 3
| 744
| 1
|
77.66699
|
male
| 1
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 15
| null | 0
| 16,398
| 13,352.3125
| null | 5.333332
|
white
| 16
| 42
| 0.86792
| 0.780884
| 1
| 1
| 0
|
no
| 0.8
| 0.512
|
no dnr
| 20
| 69
| 9.898438
| 74
| 16
| 36.79688
| 204
| 4.199219
| null | 2.299805
| 137
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.988281
| 20
| 1
|
93.75494
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 10,622
| 8,300.2734
| null | 14.5
|
white
| 21.699219
| 53
| 0.723999
| 0.56897
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
dnr after sadm
| 1
| 66
| 5.099609
| 140
| 36
| 38.69531
| null | 3.799805
| null | 1.799805
| 136
| null | null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 102
| 1
|
63.48499
|
female
| 0
| 23
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 22,166
| 18,582.3438
| null | 13.333328
|
black
| 34.296875
| 28
| 0.25
| 0.031998
| 1
| 0
| 0
|
metastatic
| 0.65
| 0.35
|
dnr after sadm
| 1
| 53
| 20.296875
| 112
| 20
| 37.29688
| null | 2.699707
| 0.5
| 0.799927
| 133
| null | null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 52
| 1
|
58.63898
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 17,714
| 11,645.3594
| null | 20.333328
|
white
| 38.195313
| 42
| 0.485962
| 0.283997
| 1
| 0
| 0
|
yes
| 0.5
| 0.02
|
no dnr
| 15
| 49
| 14.5
| 118
| 32
| 36.19531
| 243.3125
| 3.299805
| 1.299805
| 1.099854
| 124
| 7.459961
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 2,019
| 0
|
84.10095
|
female
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 9
| 42,058
| 28,787.5156
| null | 14.5
|
white
| 22.5
| 39
| 0.731934
| 0.647949
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 42
| 65
| 18.398438
| 44
| 24
| 37.29688
| 388
| 2.199707
| 1.099854
| 1.899902
| 142
| 7.329102
| null | null | null | null | 6
|
no(M2 and SIP pres)
| 6
| 1,115
| 1
|
51.52399
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 37
| 9,931
| 5,960.7148
| null | 18.5
|
white
| 24.097656
| 21
| 0.753906
| 0.67688
| 1
| 0
| 0
|
no
| 0.99
| 0.98
|
no dnr
| 10
| 63
| 3.599609
| 98
| 40
| 39.09375
| 302.5
| 3
| 0.399963
| 0.599976
| 136
| 7.439453
| null | null | null | null | null | null | 2.415039
| 2,017
| 0
|
95.56494
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 4,417
| 3,155.0312
| null | 10
|
white
| 22.199219
| 56
| 0.705933
| 0.543945
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 5
| 77
| 12.699219
| 160
| 28
| 36.69531
| 460
| 4
| 1.199951
| 1.699951
| 144
| 7.459961
| null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
| 1,668
| 1
|
55.42499
|
female
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 13
| null | 0
| 10,085
| 7,489.4961
| null | 12.5
|
white
| 32.296875
| 14
| 0.335999
| 0.066986
| 1
| 0
| 0
|
metastatic
| 0.2
| 0
|
dnr after sadm
| 2
| 73
| 8
| 104
| 24
| 37
| null | 2.599609
| 0.899902
| 0.799927
| 128
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 3.220703
| 93
| 1
|
53.42099
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 14,593
| 8,761.5156
| null | 14
|
white
| 15.199219
| 13
| 0.919922
| 0.890991
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 9
| 83
| 13.599609
| 78
| 32
| 38.29688
| null | 2.799805
| null | 1
| 138
| null | null | null | null | 0
| null | null | 0.4948
| 2,016
| 0
|
84.33099
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 17,909
| 13,563.3047
| null | 22
|
white
| 21.898438
| 34
| 0.768921
| 0.694946
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 12
| 75
| 10.398438
| 68
| 16
| 38.5
| 108
| 3.799805
| 0.299988
| 1.399902
| 142
| 7.40918
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 2,016
| 0
|
57.23199
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 9
|
$11-$25k
| 0
| 4,652
| 3,553.2793
| null | 16
|
asian
| 8.298828
| 10
| 0.853882
| 0.67688
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 5
| 107
| 7.5
| 100
| 18
| 36.89844
| null | 4.199219
| null | 0.899902
| 142
| null | null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 236
| 1
|
46.74597
|
female
| 0
| 45
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
| null | 0
| 94,302
| 24,157.2031
| null | 34
|
white
| 32
| 44
| 0.75
| 0.670898
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 45
| 103
| 3.099609
| 158
| 10
| 39.59375
| 200
| 2.199707
| 3.599609
| 0.699951
| 132
| 7.279297
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 2,015
| 0
|
87.20099
|
female
| 0
| 23
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 21,775
| 14,229.2656
| null | 10
|
white
| 14.798828
| 31
| 0.852905
| 0.757935
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 23
| 67
| 8.199219
| 88
| 24
| 38
| 453
| null | null | 1.599854
| 139
| 7.459961
| null | null | null | null | 0
| null | 0
| 217
| 1
|
80.29596
|
female
| 1
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
| null | 0
| 11,442
| 3,974.5703
| null | 26
|
white
| 20
| 20
| 0.780884
| 0.649902
| 1
| 0
| 0
|
no
| 0.3
| 0.1
|
no dnr
| 7
| 98
| 5
| 40
| 24
| 38
| 200
| null | 0.5
| 0.599976
| 141
| 7.359375
| null | null | null | 5
| 2
|
<2 mo. follow-up
| 2
| 7
| 1
|
78.26099
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 13,574
| 10,652.4219
| null | 18.5
| null | 25.296875
| 31
| 0.700928
| 0.53894
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr before sadm
| -1
| 75
| 7
| 103
| 20
| 38
| 127.5
| null | null | 1.099854
| 128
| 7.509766
| null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
| 176
| 1
|
75.99695
|
male
| 0
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 81,626
| 562.814
| null | 29.25
|
white
| 20.898438
| 37
| 0.782959
| 0.711914
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 39
| 112
| 9.298828
| 83
| 18
| 38.39844
| 196
| 3
| null | 3.799805
| 139
| 7.399414
| null | null | null | 1
| null |
adl>=4 (>=5 if sur)
| 1.1669
| 1,423
| 1
|
60.86798
|
male
| 0
| 128
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 4
| null | 9
| 259,334
| 74,035.125
| null | 25.25
|
white
| 24.296875
| 48
| 0.73291
| 0.649902
| 12
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 128
| 129
| 10.298828
| 114
| 28
| 37.19531
| 376.625
| null | null | 10.898438
| 134
| 7.339844
| null | null | null | null | 2
| null | 2
| 476
| 1
|
57.11697
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 8,150
| 5,800.4766
| null | 15
|
white
| 11.898438
| 9
| 0.809937
| 0.593994
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.4
|
no dnr
| 5
| 93
| 6.699219
| 84
| 20
| 38
| null | null | 0.399963
| 1
| 142
| null | null | null | null | null | 2
| null | 2
| 375
| 1
|
67.38898
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 6,146
| 3,244.582
| null | 6
|
white
| 14.398438
| 13
| 0.896973
| 0.826904
| 2
| 0
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 5
| 80
| null | 80
| 24
| 36.69531
| null | null | null | 1.299805
| 144
| null | null | null | null | 6
| null |
<2 mo. follow-up
| 4.527397
| 38
| 1
|
71.90094
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 15
| null | 26
| 27,244
| 20,179.2031
| null | 21
|
white
| 22.796875
| 31
| 0.598999
| 0.490967
| 6
| 0
| 0
|
yes
| null | null |
no dnr
| 9
| 75
| 6.699219
| 58
| 12
| 36
| 214.28125
| null | 0.399963
| 1.899902
| 137
| 7.399414
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 2,010
| 0
|
21.20999
|
male
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 0
| 6,719
| 3,303.125
| null | 7
|
white
| 19.5
| 45
| 0.937988
| 0.914917
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 129
| 8.298828
| 70
| 26
| 36.19531
| 306.625
| 3.099609
| 0.299988
| 12.398438
| 156
| 7.239258
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 2,009
| 0
|
53.67297
|
male
| 1
| 3
|
Coma
|
Coma
| 0
| 17
|
$11-$25k
| 100
| 6,521
| 2,071.1094
| null | 22
|
black
| 54.695313
| 81
| 0
| 0
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 33
| 5.099609
| 0
| 0
| 35.19531
| 211.65625
| 3.199707
| 0.5
| 2.399902
| 145
| 7.379883
| null | null | null | null | null |
<2 mo. follow-up
| 2.29834
| 3
| 1
|
71.45197
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 4,995
| 4,014.6133
| null | 7
|
black
| 18.097656
| 26
| 0.863892
| 0.773926
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 5
| 110
| 4.599609
| 66
| 20
| 36.79688
| 176.65625
| null | 0.299988
| 1.5
| 141
| 7.179688
| null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
| 2,008
| 0
|
76.15094
|
male
| 1
| 26
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 16,484
| 13,867.6016
| null | 3.75
|
white
| 30.097656
| 18
| 0.326965
| 0.062988
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.05
|
dnr after sadm
| 1
| 77
| 9.5
| 100
| 22
| 36.69531
| null | 2.699707
| 0.399963
| 0.699951
| 128
| null | null | null | null | 7
| 4
|
<2 mo. follow-up
| 4
| 26
| 1
|
64.99396
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 17
|
$11-$25k
| 0
| 7,826
| 3,351.7012
| null | 7
|
white
| 19.898438
| 24
| 0.862915
| 0.773926
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 6
| 73
| 4
| 114
| 20
| 36.19531
| null | null | null | 1.299805
| 137
| null | null | null | null | 0
| 0
|
SIP>=30
| 0
| 2,005
| 0
|
37.81
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 57,170
| 420.3059
| null | 36
|
white
| 44.898438
| 81
| 0.420959
| 0.301941
| 6
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 17
| 47
| 17.898438
| 147
| 40
| 38.89844
| 80
| 2.299805
| null | 2.299805
| 138
| 7.369141
| null | null | null | null | 0
| null | 0
| 2,005
| 0
|
42.01498
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 17
|
under $11k
| 0
| 9,923
| 6,147.9219
| null | 13
|
white
| 19.296875
| 23
| 0.910889
| 0.878906
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 8
| 73
| 7.599609
| 50
| 16
| 36.79688
| 309.5
| 4.699219
| 1.299805
| 0.599976
| 135
| 7.449219
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 2,004
| 0
|
62.84698
|
male
| 1
| 29
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 14
|
under $11k
| 0
| 46,029
| 28,832.4688
| null | 16
|
white
| 30.699219
| 49
| 0.36499
| 0.246979
| 8
| 1
| 0
|
metastatic
| 0.6
| 0.216
|
dnr after sadm
| 22
| 63
| 32.398438
| 66
| 28
| 36.79688
| 200
| 2.899902
| 1.099854
| 4.099609
| 128
| 7.399414
| null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 29
| 1
|
74.77899
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 9
|
under $11k
| 0
| 10,348
| 9,178.2422
| null | 8
|
white
| 19.5
| 27
| 0.815918
| 0.701904
| 3
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 7
| 65
| 11.199219
| 68
| 22
| 36
| null | null | null | 1.599854
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,769
| 1
|
79.67694
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 0
| 27,784
| 20,989
| null | 38
|
white
| 20.796875
| 34
| 0.751953
| 0.67395
| 8
| 1
| 0
|
no
| 0.4
| 0.2
|
dnr after sadm
| 1
| 73
| 12.298828
| 77
| 22
| 36.29688
| 296.625
| null | 0.299988
| 2.399902
| 137
| 7.449219
| null | null | null | 6
| 5
|
<2 mo. follow-up
| 5
| 7
| 1
|
24.78
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
under $11k
| 0
| 20,322
| 12,712.5781
| null | 16
|
black
| 24.796875
| 23
| 0.876953
| 0.832886
| 6
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 13
| 60
| 13.199219
| 115
| 28
| 37
| 204.0625
| null | null | 0.599976
| 137
| 7.459961
| null | null | null | 0
| 4
| null | 4
| 1,999
| 0
|
72.95294
|
male
| 0
| 16
|
Lung Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 13,340
| 11,943.1562
| null | 7
|
white
| 16.296875
| 18
| 0.702881
| 0.416992
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 62
| 7.699219
| 62
| 16
| 36.5
| null | 3.599609
| 0.699951
| 0.799927
| 132
| null | null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 29
| 1
|
31.56699
|
male
| 0
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 18
| null | 0
| 46,374
| 29,131.6406
| null | 13.25
|
white
| 30.097656
| 42
| 0.791992
| 0.723999
| 1
| 0
| 0
|
yes
| 1
| 0.99
|
no dnr
| 43
| 57
| 17.699219
| 130
| 34
| 39.59375
| 167.34375
| 2.699707
| 0.799927
| 1.5
| 138
| 7.379883
| null | null | null | 1
| 1
| null | 1
| 1,998
| 0
|
56.961
|
male
| 0
| 17
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 16
|
$25-$50k
| 0
| 19,128
| 13,759.375
| null | 13.666664
|
white
| 17.097656
| 26
| 0.844971
| 0.744995
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 17
| 71
| 6
| 77
| 32
| 37
| 306.625
| 2.5
| 2.5
| 0.799927
| 135
| 7.429688
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,998
| 0
|
85.31995
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 10,257
| 7,788.1328
| null | 35
|
white
| 23.097656
| 52
| 0.744995
| 0.665894
| 1
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 2
| 57
| 11.798828
| 155
| 8
| 38.69531
| 310
| 3.199707
| 0.399963
| 1.5
| 140
| 7.259766
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 5
| 1
|
65.70599
|
female
| 1
| 4
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 2,924
| 2,225.625
| null | 7
|
white
| 44.898438
| 79
| 0.139984
| 0.007999
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 53
| 0.299988
| 112
| 30
| 36.69531
| 661.625
| 1.699951
| 1.099854
| 1.399902
| 141
| 7.289062
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
87.19196
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 15,135
| 13,666.3828
| null | 31
|
white
| 48
| 68
| 0.071991
| 0.025997
| 3
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 1
| 30
| 23.699219
| 55
| 10
| 37.59375
| 197.5
| null | null | 2.5
| 130
| 7.289062
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 6
| 1
|
73.35199
|
male
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 16,690
| 13,542.2344
| null | 20.5
|
white
| 14.699219
| 26
| 0.795898
| 0.671997
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 73
| 8.298828
| 88
| 32
| 38.19531
| 350
| 2.699707
| null | 0.899902
| 146
| 7.439453
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,994
| 0
|
88.89795
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 15,777
| 8,660.6016
| null | 15
|
white
| 23
| 42
| 0.731934
| 0.647949
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 1
| 56
| 6.599609
| 51
| 12
| 37.59375
| 247.59375
| 2.5
| 0.299988
| 0.399963
| 140
| 7.429688
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 21
| 1
|
68.26294
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 5,599
| 4,413.5742
| null | 21
|
white
| 30
| 36
| 0.359985
| 0.078995
| 1
| 1
| 0
|
metastatic
| 0.5
| 0.1
|
dnr before sadm
| -1
| 77
| 13.199219
| 110
| 28
| 36
| null | 2.899902
| 0.599976
| 1
| 135
| null | null | null | null | 3
| null |
<2 mo. follow-up
| 2.511099
| 20
| 1
|
72.47595
|
male
| 0
| 38
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 55,572
| 46,378.6875
| null | 26.75
|
white
| 24
| 38
| 0.784912
| 0.654907
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 28
| 61
| 6.099609
| 97
| 9
| 38.39844
| 156
| null | null | 2.5
| 135
| 7.419922
| null | null | null | null | 0
| null | 0
| 1,993
| 0
|
64.54999
|
female
| 0
| 13
|
Lung Cancer
|
Cancer
| 1
| 15
|
$11-$25k
| 0
| 10,349
| 7,812.418
| null | 10
|
white
| 16.097656
| 11
| 0.725952
| 0.452942
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 3
| 83
| 8
| 90
| 20
| 37
| null | 3.399902
| 0.299988
| 0.799927
| 134
| null | null | null | null | 4
| null |
<2 mo. follow-up
| 3.183199
| 25
| 1
|
77.32495
|
male
| 0
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
>$50k
| 0
| 12,638
| 8,273.2656
| null | 19
|
white
| 25.699219
| 48
| 0.603882
| 0.497986
| 3
| 0
| 0
|
yes
| 0
| 0
|
no dnr
| 7
| 107
| 100
| 82
| 30
| 37.69531
| 122.5
| null | 1.5
| 1.5
| 146
| 7.439453
| null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 34
| 1
|
73.91095
|
male
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 46,732
| 21,987.5
| null | 33.666657
|
white
| 19.097656
| 31
| 0.842896
| 0.78894
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 13
| 77
| 9.699219
| 80
| 30
| 38.39844
| 166
| null | null | 1.099854
| 133
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 2.598145
| 14
| 1
|
61.43997
|
female
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 11
|
under $11k
| 0
| 9,601
| 7,848.5742
| null | 9
|
black
| 17.097656
| 35
| 0.823975
| 0.712891
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 12
| 77
| 6.199219
| 94
| 16
| 36
| null | null | null | 18.398438
| 137
| null | null | null | null | 5
| 3
|
no(M2 and SIP pres)
| 3
| 1,990
| 0
|
74.33795
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 6,024
| 4,765.9258
| null | 8
|
white
| 16.699219
| 36
| 0.856934
| 0.763916
| 1
| 0
| 0
|
no
| 0.8
| 0.4
|
dnr after sadm
| 1
| 81
| 9.5
| 84
| 32
| 37.29688
| 195.21875
| null | null | 1
| 142
| 7.319336
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 3.07666
| 85
| 1
|
51.461
|
female
| 0
| 27
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 37
| 30,321
| 23,567.2188
| null | 9.75
|
white
| 28.898438
| 64
| 0.529907
| 0.330994
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 27
| 73
| 8.578125
| 140
| 22
| 38.59375
| 384
| 2.199707
| 17.699219
| 1.599854
| 135
| 7.379883
| null | null | null | null | null |
SIP>=30
| 3.533203
| 1,989
| 0
|
61.98499
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 20
|
$11-$25k
| 0
| 3,503
| 2,697.7246
| null | 4
|
white
| 16.5
| 16
| 0.828979
| 0.628906
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 5
| 93
| 10.599609
| 60
| 20
| 37
| null | null | null | 1.299805
| 138
| null | null | null | null | 3
| 2
|
no(M2 and SIP pres)
| 2
| 1,988
| 0
|
89.36597
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 4,119
| 3,051.9258
| null | 12
|
white
| 17.199219
| 30
| 0.815918
| 0.700928
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
dnr after sadm
| 2
| 73
| 4.899414
| 74
| 28
| 36.09375
| 276
| null | null | 1.299805
| 144
| 7.419922
| null | null | null | 6
| null |
adl>=4 (>=5 if sur)
| 4.527397
| 167
| 1
|
85.85596
|
male
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 10,144
| 7,912.125
| null | 14.5
|
white
| 21.398438
| 49
| 0.715942
| 0.557983
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 105
| 3.299805
| 78
| 22
| 35.89844
| 233.3125
| null | null | 3
| 140
| 7.289062
| null | null | null | 5
| 3
|
adl>=4 (>=5 if sur)
| 3
| 69
| 1
|
83.69299
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 9
| 8,571
| 7,353.4258
| null | 23
|
white
| 15.398438
| 21
| 0.839966
| 0.784912
| 1
| 0
| 1
|
no
| null | null |
dnr before sadm
| -1
| 60
| 9.398438
| 64
| 24
| 38.29688
| 266.625
| null | null | 0.599976
| 142
| 7.449219
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 4.782227
| 1,237
| 1
|
50.36798
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 20
|
>$50k
| 0
| 10,558
| 7,541.6172
| null | 12
|
white
| 10.798828
| 11
| 0.833984
| 0.637939
| 1
| 0
| 0
|
metastatic
| 0.78
| 0.1
|
no dnr
| 7
| 103
| 11.099609
| 96
| 24
| 38.19531
| null | 3.899902
| null | 1.199951
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 427
| 1
|
69.435
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 2,722
| 1,893.0508
| null | 5
|
white
| 21
| 25
| 0.836914
| 0.73291
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 92
| 10.699219
| 74
| 20
| 36.39844
| 388
| null | null | 2.599609
| 136
| 7.419922
| null | null | null | null | null |
no(M2 and SIP pres)
| 1.954346
| 1,985
| 0
|
81.57196
|
female
| 1
| 33
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 42,506
| 25,386.0312
| null | 16.25
|
white
| 27.097656
| 41
| 0.615967
| 0.428955
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 26
| 113
| 6.899414
| 134
| 42
| 38.59375
| 304
| 2.699707
| 0.599976
| 0.899902
| 132
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.264648
| 33
| 1
|
75.16498
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 9
| 19,845
| null | null | 12
| null | 23.5
| 25
| 0.695923
| 0.60498
| 1
| 0
| 0
|
yes
| 0.8
| 0.6
|
dnr before sadm
| -1
| 83
| 6.699219
| 60
| 24
| 36.19531
| 188.3125
| 3.199707
| 1.099854
| 2.199707
| 141
| 7.339844
| null | null | null | null | null |
<2 mo. follow-up
| 3.395508
| 39
| 1
|
28.411
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 15,781
| 8,793.8828
| null | 16.5
|
white
| 24.5
| 36
| 0.895996
| 0.858887
| 1
| 0
| 0
|
no
| 0.95
| 0.94
|
no dnr
| 11
| 57
| 8.398438
| 117
| 44
| 38.39844
| 177.5
| 3.599609
| 0.399963
| 0.699951
| 137
| 7.399414
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.370606
| 1,982
| 0
|
75.80298
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 20,469
| 11,248.2812
| null | 20.333328
|
white
| 25.199219
| 54
| 0.746948
| 0.667969
| 1
| 1
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 15
| 130
| 20
| 126
| 36
| 38.59375
| 289
| null | null | 1.799805
| 143
| 7.399414
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 3.375977
| 265
| 1
|
40.77798
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 17
|
$11-$25k
| 0
| 15,497
| 6,732.6719
| null | 24.5
|
white
| 25.699219
| 50
| 0.856934
| 0.807983
| 1
| 1
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 10
| 61
| 15
| 110
| 26
| 36.29688
| 386.625
| 2.299805
| null | 2
| 136
| 7.269531
| null | null | null | 1
| 0
| null | 0
| 1,983
| 0
|
63.10699
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 40,364
| 27,025.0312
| null | 20.5
|
white
| 20.398438
| 32
| 0.831909
| 0.725952
| 6
| 1
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 11
| 106
| 7.299805
| 62
| 6
| 34.79688
| 341
| null | null | 1.199951
| 134
| 7.509766
| null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
| 220
| 1
|
81.40997
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 9
| 15,727
| 13,627.2422
| null | 26.5
|
white
| 18.597656
| 22
| 0.805908
| 0.741943
| 1
| 0
| 0
|
no
| 0.7
| 0.4
|
no dnr
| 11
| 61
| 5.199219
| 89
| 11
| 36.39844
| 210.1875
| null | null | 1.199951
| 139
| 7.439453
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.939453
| 158
| 1
|
83.51495
|
female
| 1
| 9
|
Coma
|
Coma
| 2
| 12
|
under $11k
| 100
| 21,857
| 9,337.4766
| null | 34.5
|
white
| 27.097656
| 49
| 0.019997
| 0.007999
| 3
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 6
| 133
| 18.796875
| 105
| 38
| 37.29688
| 208
| 2.899902
| null | 2.299805
| 133
| 7.40918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 9
| 1
|
46.27798
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 6,112
| 4,393.9492
| null | 15
|
white
| 15.5
| 10
| 0.774902
| 0.530884
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.9
|
no dnr
| 5
| 93
| 8.699219
| 110
| 20
| 36.19531
| null | 3.299805
| null | 0.899902
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,979
| 0
|
65.06494
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 9,324
| 6,639.1523
| null | 18
|
white
| 6.5
| 11
| 0.862915
| 0.69397
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 87
| 7.799805
| 70
| 20
| 37
| null | 3.199707
| 0.5
| 1.199951
| 140
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 173
| 1
|
71.84399
|
female
| 0
| 142
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 100
| 247,553
| null | null | 34.25
|
white
| 25
| 36
| 0.199982
| 0.106995
| 33
| 0
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 17
| 108
| 13.298828
| 112
| 37
| 40.19531
| 308
| null | null | 0.699951
| 145
| 7.459961
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 1,978
| 0
|
57.85599
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 11
|
$11-$25k
| 0
| 6,191
| 4,342.793
| null | 18
|
black
| 14.199219
| 7
| 0.773926
| 0.529907
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 99
| 6.099609
| 80
| 20
| 36.59375
| null | null | null | 1.199951
| 144
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.955811
| 1,978
| 0
|
91.35394
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 41
| 9,472
| 5,058.6484
| null | 14.5
|
black
| 20.296875
| 41
| 0.621948
| 0.517944
| 1
| 0
| 1
|
no
| 0.5
| 0.3
|
dnr after sadm
| 1
| 77
| 7.699219
| 104
| 26
| 37.29688
| 593.25
| 1.799805
| 0.699951
| 1.399902
| 156
| 7.419922
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 6.267578
| 287
| 1
|
84.32599
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 8,797
| 6,918.1875
| null | 15
|
white
| 23.097656
| 32
| 0.744995
| 0.598999
| 1
| 0
| 0
|
no
| 0.7
| 0.343
|
no dnr
| 11
| 82
| 8.699219
| 58
| 28
| 37
| 360
| null | null | 3.399902
| 140
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 589
| 1
|
69.74097
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 6,911
| 5,281.0781
| null | 8
|
white
| 40.398438
| 43
| 0.23999
| 0.028999
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 1
| 96
| 13.199219
| 94
| 18
| 37.5
| null | 2.399902
| 25.597656
| 1.299805
| 132
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
77.75995
|
male
| 1
| 37
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 35,881
| 29,816.2656
| null | 12.5
|
white
| 28
| 46
| 0.685913
| 0.518921
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 23
| 44
| 7.899414
| 76
| 24
| 35.79688
| 376.1875
| null | null | 1.599854
| 136
| 7.5
| null | null | null | 1
| 3
|
<2 mo. follow-up
| 3
| 37
| 1
|
50.59
|
male
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 17
|
>$50k
| 0
| 49,205
| 44,503.75
| null | 28.25
|
white
| 41.5
| 67
| 0.511963
| 0.395996
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 26
| 43
| 3.799805
| 78
| 10
| 36.19531
| 142
| 2.099609
| 0.399963
| 7
| 132
| 7.089844
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,973
| 0
|
73.336
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 50,127
| 37,894.8438
| null | 24.75
|
white
| 23.898438
| 36
| 0.726929
| 0.641968
| 7
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 25
| 109
| 12.298828
| 66
| 26
| 38.19531
| 147.5
| 3.099609
| 2.399902
| 1.399902
| 135
| 7.489258
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 1,944
| 1
|
82.60394
|
female
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 38,687
| 27,226.2812
| null | 12.25
|
white
| 23.398438
| 49
| 0.674927
| 0.579956
| 2
| 0
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 31
| 57
| 8
| 49
| 22
| 36.39844
| 300
| 3.399902
| 0.5
| 2.299805
| 134
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,471
| 1
|
52.49597
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
>$50k
| 0
| 12,827
| 10,778.3125
| null | 25.5
|
white
| 28.597656
| 32
| 0.782959
| 0.711914
| 1
| 1
| 0
|
no
| 0.96
| 0.95
|
no dnr
| 10
| 116
| 5
| 51
| 24
| 36.59375
| 148.96875
| 2.199707
| 1.299805
| 2.199707
| 138
| 7.349609
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,971
| 0
|
82.34094
|
male
| 1
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 4
| null | 0
| 4,338
| 3,098.4258
| null | 11
|
white
| 25.699219
| 38
| 0.480957
| 0.278992
| 1
| 0
| 0
|
no
| 0.6
| 0.3
|
dnr after sadm
| 4
| 87
| 15
| 124
| 23
| 38.79688
| 246.40625
| 3.199707
| 7.199219
| 1.099854
| 136
| 7.529297
| null | null | null | null | null |
<2 mo. follow-up
| 2.725586
| 4
| 1
|
39.896
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 5,221
| 3,690.5723
| null | 8
|
white
| 17.898438
| 30
| 0.897949
| 0.828979
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 93
| 5.099609
| 104
| 28
| 37.29688
| null | 1.799805
| 1
| 1.299805
| 136
| null | null | null | null | null | null | null | 1.863525
| 1,001
| 1
|
70.83899
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 8
| null | 0
| 15,529
| 6,593.3281
| null | 18
|
white
| 23.296875
| 39
| 0.791992
| 0.665894
| 1
| 1
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 10
| 53
| 4.799805
| 52
| 28
| 36.59375
| 200
| 3.599609
| 0.199982
| 0.799927
| 137
| 7.429688
| null | null | null | 0
| null |
SIP>=30
| 0.4948
| 1,227
| 1
|
66.61694
|
male
| 0
| 24
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 21,410
| 19,480.0312
| null | 10.333328
|
white
| 17.796875
| 22
| 0.803955
| 0.581909
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 4
| 86
| 2.699707
| 60
| 8
| 36.89844
| null | 3.399902
| 0.599976
| 0.899902
| 141
| null | null | null | null | 7
| 1
|
<2 mo. follow-up
| 1
| 31
| 1
|
45.06998
|
female
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 11,897
| 8,689.2031
| null | 13.5
|
white
| 19.898438
| 5
| 0.696899
| 0.408997
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 11
| 81
| 9.398438
| 80
| 20
| 37.79688
| null | 2.599609
| null | 0.899902
| 136
| null | null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 256
| 1
|
54.28299
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
$25-$50k
| 0
| 15,118
| 6,624.2617
| null | 22.5
|
white
| 37.5
| 52
| 0.594971
| 0.487
| 1
| 0
| 0
|
no
| 0.8
| 0.65
|
no dnr
| 10
| 50
| 10
| 155
| 40
| 37.29688
| 95
| 3
| 1.799805
| 0.899902
| 140
| 7.289062
| null | null | null | null | 2
| null | 2
| 335
| 1
|
68.44897
|
male
| 1
| 172
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$11-$25k
| 0
| 357,428
| 306,873.5
| null | 42
|
white
| 29.699219
| 60
| 0.606934
| 0.5
| 14
| 0
| 0
|
no
| 0.2
| 0.09
|
no dnr
| 172
| 107
| 15.699219
| 88
| 18
| 37.5
| 188.3125
| 2.099609
| 7.799805
| 7
| 134
| 7.40918
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 172
| 1
|
87.09698
|
female
| 0
| 27
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 42,836
| 33,844.75
| null | 21.5
|
white
| 18.898438
| 25
| 0.800903
| 0.679932
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 27
| 104
| 24.597656
| 80
| 34
| 38
| 355.0625
| null | 0.599976
| 0.899902
| 130
| 7.40918
| null | null | null | 2
| 2
|
no(M2 and SIP pres)
| 2
| 71
| 1
|
90.81195
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null |
under $11k
| 0
| 40,846
| 6,658.1758
| null | 13
|
white
| 17.5
| 30
| 0.805908
| 0.68689
| 1
| 1
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 11
| 111
| 8.398438
| 48
| 16
| 36.89844
| 293.3125
| 3.699707
| 0.399963
| 1.699951
| 138
| 7.429688
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 72
| 1
|
46.72699
|
female
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 2,666
| 2,077.2012
| null | 11
|
white
| 13.699219
| 11
| 0.909912
| 0.8479
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 77
| 9.898438
| 80
| 20
| 37.59375
| null | null | 1.099854
| 0.899902
| 143
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 452
| 1
|
65.20197
|
male
| 1
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 14
|
under $11k
| 9
| 14,254
| 11,676.5625
| null | 7.666664
|
white
| 24.898438
| 43
| 0.62793
| 0.44397
| 1
| 0
| 1
|
no
| null | 0.09
|
dnr after sadm
| 2
| 77
| 13.199219
| 54
| 24
| 35.69531
| 182.59375
| 2.299805
| 3
| 0.799927
| 142
| 7.469727
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 14
| 1
|
48.94998
|
male
| 0
| 25
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 34,640
| 29,713.7656
| null | 24
|
white
| 21.699219
| 34
| 0.886963
| 0.81189
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 25
| 43
| 6.099609
| 69
| 20
| 36.09375
| 480
| 4.599609
| 0.899902
| 1.399902
| 133
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 161
| 1
|
80.70599
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 9
| 9,764
| 4,184.7578
| null | 28
|
white
| 21.199219
| 42
| 0.767944
| 0.69397
| 1
| 0
| 1
|
no
| 0.6
| 0.5
|
dnr after sadm
| 1
| 78
| 8.099609
| 73
| 28
| 37.5
| 204
| 3.899902
| null | 2.799805
| 147
| 6.959961
| null | null | null | null | 5
| null | 5
| 1,957
| 0
|
60.31497
|
female
| 0
| 23
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 26,095
| 19,613.9844
| null | 15
|
black
| 11.599609
| 25
| 0.93396
| 0.888916
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 23
| 69
| 8.599609
| 76
| 24
| 36.89844
| null | 4.099609
| 1.399902
| 1.299805
| 134
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 49
| 1
|
80.64099
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 8,667
| 6,495.2734
| null | 10
|
white
| 21.296875
| 35
| 0.757935
| 0.615967
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 9
| 93
| 11.5
| 84
| 22
| 36.69531
| 191.28125
| 3.199707
| null | 1.599854
| 136
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 4.333008
| 56
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.